Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113735867B reveals mild synthesis for antitumor intermediates. Offers high yield and enantioselectivity for cost-effective supply chain solutions.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering reliable supply chain solutions.
Patent CN110683926B reveals a robust Pd-catalyzed method for direct C-O coupling, offering high yields and broad substrate scope for reliable pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.
Patent CN118878452B reveals a mild catalytic route for anti-tumor intermediates. This report analyzes supply chain stability and cost reduction in pharma manufacturing.
Novel synthesis route for Orforglipron intermediate reduces waste and cost. Reliable supply chain for GLP-1 drug precursors.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Patent CN113980044B reveals a novel Ir-O-P catalyzed diboration method. This breakthrough enables cost-effective, scalable production of high-purity organoboron intermediates for drug discovery.
Novel synthesis method offers mild conditions and high yield for pharmaceutical intermediates ensuring cost reduction and supply chain reliability for global partners seeking advanced antitumor solutions
Novel synthesis method for chiral indolo compounds with high enantioselectivity. Cost-effective manufacturing for pharmaceutical applications ensuring supply chain reliability.
Patent CN120923511A details mild synthesis of chiral vinyl indolo compounds. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111217693A details a cuprous halide catalyzed carboxylation method using CO2, offering cost-effective routes for high-purity pharmaceutical intermediates and fine chemicals.
Patent CN110467555A reveals mild chiral phosphoric acid catalysis for high-purity pharmaceutical intermediates. Enables cost reduction and supply chain reliability for global buyers.
Novel isoindolone-based antitumor compound synthesis via patent CN119874717B. Mild conditions, high yield. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN111217847B introduces efficient thiosilane ligands for aryl boronation, offering high yield and purity for reliable pharmaceutical intermediate supply chains.
Patent CN115385916B details a novel chiral phosphoric acid catalyzed route offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110452150B details a mild, one-step synthesis of axial chiral indole-naphthalenes with high enantioselectivity, offering cost-effective solutions for chiral catalyst manufacturing.
Patent CN112939841B enables low-cost synthesis of chiral amino acid intermediates without palladium catalysts, ensuring scalable supply chain reliability.
Patent CN103483267B reveals a high-yield one-pot synthesis for aryl imidazole salts, enabling cost reduction in pharma intermediate manufacturing and reliable supply chain scalability.